Study of SNS851 for people with high liver fat
Part of Hormones & metabolism clinical trials.
This study tests a new medicine called SNS851 in healthy volunteers to see if it is safe and tolerable. It may help people with high liver fat, though it is not yet known if it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 55 years old (or up to 60 in some parts of the study)
- Have a body mass index (BMI) between 18 and 32
- Have higher than normal liver fat levels
- Be generally healthy with no major health conditions
- Not smoke or use nicotine products
- Avoid caffeine and certain foods/drinks during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication for people with fatty liver disease. It will see if the drug can reduce liver fat and improve liver health over several doses.
This study checks how a new medicine (called NNC0487-0111) moves through the body and how safe it is for people with different levels of liver function. If you have stable liver disease or normal liver function, you might help researchers learn how the medicine works.
This study tests an experimental drug called SNP-610 for a liver condition called NASH (fatty liver with inflammation). The goal is to see if the drug helps improve liver health compared to a placebo.
This trial tests a new drug called HP515 for people with non-alcoholic fatty liver disease, including NASH or MASH. It aims to see if the drug can help reduce liver fat and improve liver health.
This trial tests an experimental pill called CS060380 for people with NASH (a type of fatty liver disease that can cause liver damage). You may qualify if you have a liver biopsy showing NASH with early-to-moderate scarring, or an MRI showing at least 10% liver fat, and your liver enzymes are stable.
This study checks how a new tablet moves through the body and if it is safe for people with mild or moderate liver problems compared to people with healthy livers. It might help doctors understand how to dose the drug for people like you.
Hear when a new Metabolic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.